急诊经皮冠状动脉介入治疗术后对比剂诱导的急性肾损伤的危险因素
本文选题:对比剂诱导的急性肾损伤 + 急诊经皮冠状动脉介入治疗 ; 参考:《北京协和医学院》2017年硕士论文
【摘要】:第一部分:急诊经皮冠状动脉介入治疗术后对比剂诱导的急性肾损伤的危险因素分析目的:目前关于对比剂诱导的急性肾损伤(contrast-induced acute kidney injury,CI-AKI)的研究主要立足于择期行经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)的患者,而行急诊PCI的患者术后出现CI-AKI的危险因素目前尚不完全明确。本研究将在中国人群中探索急诊PCI术后CI-AKI的危险因素。方法:选取2013年1月至2015年6月于中国医学科学院阜外医院行急诊PCI的患者共1061例纳入研究。将所有患者分为CI-AKI组和非CI-AKI组,进行单因素和多因素分析确定急诊PCI术后发生CI-AKI的危险因素。CI-AKI定义为接触碘对比剂后3日内,与基线水平相比,血肌酐值(serumcreatinine,SCr)增高≥25%或≥0.5 mg/dL(44.2 μ mol/L)。结果:行急诊PCI的患者CI-AKI发生率为22.7%(241/1061)0Logistic多因素分析显示体表面积(body surface area,BSA)[OR 0.213,95%CI:0.075-0.607,P=0.004],心肌梗死史[OR 1.642,95%CI:1.079-2.499,P=0.021],术前左室射血分数(left ventricular ejection fraction,LVEF)[OR 0.969,95%CI:0.944-0.994,P=0.015],术前血红蛋白(hemoglobin,Hb)[OR0.988,95%CI:0.976-1.000,P=0.045],术前估算的肾小球滤过率(estimated glomerular filtration rate,eGFR)[OR 1.027,95%CI:1.018-1.037,P0.001],于左前降支(left anterior descending,LAD)置入支架[OR 1.464,95%CI:1.000-2.145,P=0.050]和应用利尿剂[OR 1.850,95%CI,1.233-2.777,P=0.003]是行急诊PCI的患者术后发生CI-AKI的独立预测因素。结论:在行急诊PCI的患者中,伴有MI史、BSA较小、术前LVEF、Hb水平较低、术前eGFR较高、于LAD置入支架以及应用利尿剂的患者术后发生CI-AKI的风险较高。第二部分:行急诊经皮冠状动脉介入治疗的患者血浆大内皮素-1水平与对比剂诱导的急性肾损伤的相关性分析目的:随着经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)技术广泛应用于冠心病的治疗,对比剂诱导的急性肾损伤(contrast-induced acute kidney injury,CI-AKI)已成为冠脉介入治疗的严重并发症之一。研究证明血管内皮功能紊乱是CI-AKI发生的重要机制,本研究将探索行急诊PCI的冠心病患者血浆大内皮素-1水平与术后CI-AKI的相关性。方法:选取2013年1月到2015年6月于中国医学科学院阜外医院行急诊PCI的患者共1061例纳入研究。根据大内皮素-1分布将患者分为低水平、中等水平和高水平三组,分析三组患者基线资料和介入操作特征,以及三组间CI-AKI发生率和术后6月、12月复合终点事件(包括非致死性心肌梗死、再次血运重建、脑卒中和全因死亡)发生率的差异,并进行logistic分析明确CI-AKI的危险因素。CI-AKI定义为接触碘对比剂后3日内,与基线水平相比,血肌酐值(serum creatinine,SCr)增高≥ 25%或≥ 0.5 mg/dL(44.2 μ mol/L)。结果:行急诊PCI的患者术后CI-AKI发生率为22.7%(241/1061)。CI-AKI发生率和6月、12月复合终点发生率在大内皮素-1低、中、高水平的患者中有明显的统计学差异(P分别为0.001,0.001和0.026)。高水平大内皮素-1的患者CI-AKI发生率显著高于低水平(P0.001)和中等水平者(P=0.008)。校正其他变量后,大内皮素-1不论作为连续性变量还是分类变量均显著增加急诊PCI术后CI-AKI的风险。结论:高水平大内皮素-1与急诊PCI患者术后CI-AKI的发生密切相关,血管内皮功能紊乱可能是CI-AKI发生发展的重要机制。第三部分:急诊经皮冠状动脉介入治疗术后对比剂诱导的急性肾损伤新型风险评估模型目的:目前冠心病患者经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)术后发生对比剂诱导的急性肾损伤(contrast-induced acute kidney injury,CI-AKI)的风险评分系统大多基于行择期手术的病例资料,并不完全适用于行急诊PCI的患者,而行急诊PCI的患者术后发生CI-AKI的危险因素及其累积效应尚未在大型队列研究中得到很好的探索。本研究的目的是在行急诊PCI的患者中建立一种新的CI-AKI风险评估模型用以评估急诊PCI患者术后CI-AKI的发生风险,并对新建立的风险模型进行初步验证,以便更好地预防急诊PCI患者术后CI-AKI的发生。方法:本研究将2013年1月至2015年6月期间于中国医学科学院阜外医院行急诊PCI的患者共1061例纳入研究。按照手术的时间将所有入选的患者分为两组人群:推导并建立新型风险评分系统的推导组人群(n=761)和对风险评分系统进行初步验证的验证组人群(n=300)。本研究中CI-AKI定义为以下三者之一:一,与基线血肌酐值(serum creatinine,SCr)相比,患者术后72小时内SCr升高≥25%;二,与基线SCr相比,患者术后72小时内SCr升高≥0.5 mg/dL(44.2 μmol/L);三,与基线SCr相比,患者术后7日内SCr升高≥0.5mg/dL(44.2μmol/L)。探索并根据最适宜急诊PCI患者的定义建立此新型风险模型。结果:根据CI-AKI的不同定义,急诊PCI术后CI-AKI的发生率分别为23.5%(定义一即术后72小时内SCr升高≥25%),4.3%(定义二即术后72小时内SCr升高≥0.5 mg/dL或44.2 μ mol/L)和7.0%(定义三即术后7日内SCr升高≥0.5 mg/dL或44.2μmol/L)。鉴于定义一的高敏感性和定义二对晚发CI-AKI具有较大漏诊率,本研究中新型风险模型的建立依据定义三。在行急诊PCI的患者中建立的CI-AKI新型风险评分系统由6个变量组成,各变量及赋值为:体表面积1.6 m2(3分),短暂性脑缺血发作(transient ischemic attack,TIA)/中风史(3 分),白细胞计数(white blood cell count,WBC)15.00X 109/L(2 分),估算的肾小球滤过率(estimated glomerular filtration rate,eGFR)60ml/min·1.73m2(3 分)或基线 SCr133μmol/L(4 分),应用主动脉内球囊反搏术(intro-aortic balloon pump,IABP)(3分)和应用利尿剂(7分)。新型风险评分模型无论在推导组人群还是验证组人群均显示出了良好预测性(推导组人群:c-统计量=0.846,95%CI:0.791-0.901;验证组人群:c-统计量=0.845,95%CI:0.788-0.902)。根据新型风险模型对急诊PCI患者进行CI-AKI风险分层:低风险组(≤5分),中等风险组(6至10分),高风险组(11至15分)和极高风险组(≥16分)。在行急诊PCI的患者中CI-AKI的发生率随着风险分级的增加呈指数形式增长(P0.001)。结论:新型风险评分模型应用简单,可准确预测急诊PCI患者术后CI-AKI的发生风险并对患者进行CI-AKI风险分层。
[Abstract]:Part one: analysis of the risk factors for acute renal injury induced by contrast agent after percutaneous coronary intervention: the present study of contrast-induced acute kidney injury (CI-AKI) on contrast induced acute renal injury (CI-AKI) is mainly based on selective percutaneous coronary intervention (percutaneous coronary interve). Ntion, PCI) patients, but the risk factors for postoperative CI-AKI in emergency PCI patients are still not completely clear. This study will explore the risk factors of CI-AKI after emergency PCI in Chinese population. Methods: 1061 cases of emergency PCI from January 2013 to June 2015 in Fuwai Hospital of the Chinese Academy of Medical Sciences were included. Patients were divided into CI-AKI group and non CI-AKI group. Single factor and multifactor analysis were used to determine the risk factor for CI-AKI after PCI operation..CI-AKI was defined as the iodine contrast agent within 3 days. The serum creatinine value (serumcreatinine, SCr) increased more than 25% or more than 0.5 mg/dL (44.2 u mol/L) compared with the baseline level. The incidence of 22.7% (241/1061) 0Logistic multivariate analysis showed that the body surface area (body surface area, BSA) [OR 0.213,95%CI:0.075-0.607, P=0.004], [OR 1.642,95%CI:1.079-2.499 in the history of myocardial infarction, P=0.021], preoperative left ventricular ejection fraction. Hemoglobin, Hb [OR0.988,95%CI:0.976-1.000, P=0.045], estimated glomerular filtration rate, eGFR [OR 1.027,95%CI:1.018-1.037, P0.001]. 2.777, P=0.003] is an independent predictor of postoperative CI-AKI in patients with emergency PCI. Conclusion: in patients undergoing emergency PCI, with the history of MI, BSA is smaller, the preoperative LVEF, Hb level is low, the preoperative eGFR is higher, the risk of CI-AKI on the stent and the use of diuretics in patients with LAD is higher. The second part: emergency percutaneous coronary movement Correlation analysis between plasma endothelin -1 level and contrast induced acute renal injury in patients with pulse interventional therapy Objective: with percutaneous coronary intervention (percutaneous coronary intervention, PCI) technique widely used in the treatment of coronary heart disease, the contrast agent induced acute renal injury (contrast-induced acute kidney injury, C) I-AKI) has become one of the serious complications of coronary intervention. The study has proved that vascular endothelial dysfunction is an important mechanism for the occurrence of CI-AKI. This study will explore the correlation between the level of plasma endothelin -1 in patients with coronary heart disease in emergency PCI and postoperative CI-AKI. Methods: from January 2013 to June 2015 in the Chinese Academy of Medical Sciences. A total of 1061 patients with PCI were enrolled in the study. According to the -1 distribution of the macroendothelin, the patients were divided into three groups of low, medium and high levels. The baseline data and intervention features of the three groups were analyzed, and the incidence of CI-AKI in the three groups and the combined endpoints of June and December after the operation (including non fatal myocardial infarction, re revascularization, The difference in the incidence of cerebral apoplexy and all cause death, and logistic analysis that the risk factor for CI-AKI was defined as.CI-AKI within 3 days after exposure to the iodine contrast agent, and the serum creatinine (serum creatinine, SCr) increased more than 25% or more than 0.5 mg/dL (44.2 mu mol/L) compared with baseline levels. Results: the incidence of CI-AKI in patients with emergency PCI was 22.7% (2). 41/1061) the incidence of.CI-AKI and the incidence of the compound end point in June and December at the low level of the great endothelin -1 (P was 0.001,0.001 and 0.026). The incidence of CI-AKI in patients with high level endothelin -1 was significantly higher than those of low level (P0.001) and middle level (P=0.008). Correction of other variables, large endothelium -1, either as a continuous variable or a classified variable, significantly increases the risk of CI-AKI after emergency PCI operation. Conclusion: high level endothelin -1 is closely related to the occurrence of postoperative CI-AKI in emergency PCI patients. Vascular endothelial dysfunction may be an important mechanism for the development of CI-AKI. The third part: emergency percutaneous coronary intervention therapy A new risk assessment model for acute renal injury induced by post contrast agents Objective: the risk scoring system for acute renal injury induced by contrast agents (contrast-induced acute kidney injury, CI-AKI) after percutaneous coronary intervention (percutaneous coronary intervention, PCI) in patients with coronary heart disease is mostly based on elective surgery. Case data are not fully applicable to patients with emergency PCI, but the risk factors and cumulative effects of postoperative CI-AKI in emergency PCI patients have not been well explored in large cohort studies. The purpose of this study is to establish a new CI-AKI risk assessment model in emergency PCI patients to assess emergency PCI suffering. The risk of postoperative CI-AKI and a new risk model were preliminarily verified in order to better prevent the occurrence of CI-AKI after operation for emergency PCI patients. Methods: 1061 cases of emergency PCI were enrolled from January 2013 to June 2015 in Fuwai Hospital of the Chinese Academy of Medical Sciences. The selected patients were divided into two groups: the derivation and establishment of a new type of risk scoring system (n=761) and a preliminary verification group (n=300). In this study, CI-AKI was defined as one of the following three: one, compared with baseline serum creatinine (serum creatinine, SCr), SCr increased within 72 hours after the operation. More than 25%, two, compared with baseline SCr, the SCr increased more than 0.5 mg/dL (44.2 mu mol/L) within 72 hours after the operation; three, compared with baseline SCr, the patients were higher than 0.5mg/dL (44.2 mu mol/L) within 7 days after operation. Explore and establish this new risk model according to the definition of the most appropriate emergency PCI patients. The incidence of SCr was 23.5% (defined as higher than 25% within 72 hours after the operation), 4.3% (definition two that SCr increased more than 0.5 mg/dL or 44.2 mol/L within 72 hours after operation) and 7% (definition three, SCr elevation above 0.5 mg/dL or 44.2 mol/L within 72 days after operation). In view of the Gao Mingan nature of the first definition and the greater leakage rate for late CI-AKI The establishment of a new risk model in the study was based on definition three. The new CI-AKI risk scoring system established in the patients undergoing emergency PCI was composed of 6 variables. The variables and assignments were: body surface area 1.6 M2 (3), transient ischemic attack (transient ischemic attack, TIA) / stroke history (3), leukocyte count (white blood cell count, WB) C) 15.00X 109/L (2), estimated glomerular filtration rate (estimated glomerular filtration rate, eGFR) 60ml/min 1.73m2 (3) or baseline mol/L (4). Intra aortic balloon counterpulsation (3) and diuretic (7). The new risk score model is in the derivation group or the test The group showed good predictability (derivation group: c- statistics =0.846,95%CI:0.791-0.901; verifying group: c- statistics =0.845,95%CI:0.788-0.902). CI-AKI risk stratification for emergency PCI patients based on the new risk model: low risk group (less than 5), medium risk group (6 to 10), high risk group (11 to 15 points) and high level. The risk group (> 16). The incidence of CI-AKI in the emergency PCI patients increased exponentially with the increase of risk classification (P0.001). Conclusion: the new risk scoring model is simple to predict the risk of CI-AKI after the operation of emergency PCI patients and to make CI-AKI risk stratification for the patients.
【学位授予单位】:北京协和医学院
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R541.4;R692.5
【相似文献】
相关期刊论文 前10条
1 蒋仕林;急性肾损伤诊断和治疗(附48例分析)[J];广西医学;2002年09期
2 廖昌兴;卢晓玲;曾宪凤;;基层医院获得性急性肾损伤的临床特征[J];内科;2007年04期
3 刘天戟;韩冬梅;;125例急性肾损伤诊治体会[J];中国实验诊断学;2007年09期
4 张琳琳;周树生;刘宝;;急性肾损伤早期诊断生物标记物的研究进展[J];中国急救复苏与灾害医学杂志;2008年12期
5 谢潮鑫;孟猛;朱敏敏;蒋兰丽;;急性肾损伤50例临床分析[J];中国中西医结合肾病杂志;2008年12期
6 唐舸;;主动脉夹层动脉瘤并急性肾损伤4例[J];中国血液净化;2009年05期
7 梅长林;;加强急性肾损伤的基础及临床研究,不断提高诊治水平[J];上海医学;2009年03期
8 张益民;;急性肾损伤的远期预后[J];中国中西医结合肾病杂志;2009年07期
9 张小刚;张小丽;;36例急性肾损伤病因及预后分析[J];中国中西医结合肾病杂志;2010年04期
10 戴晖;;47例老年慢性肾脏病合并急性肾损伤相关因素的分析[J];中国中西医结合肾病杂志;2010年06期
相关会议论文 前10条
1 王琴;牟姗;严玉澄;顾乐怡;朱铭力;周文彦;施蓓莉;倪兆慧;;院内慢性肾脏病基础上急性肾损伤的调查[A];第十一届全国中西医结合肾脏病学术会议论文汇编[C];2010年
2 李雪梅;;药物导致的急性肾损伤[A];中华医学会肾脏病学分会2010学术年会专题讲座汇编[C];2010年
3 周奕菁;徐宏;;慢性肾脏病基础上的急性肾损伤的相关因素分析[A];2007年浙沪两地肾脏病学术年会资料汇编[C];2007年
4 刘朋飞;冯业童;董超;刘迪;吴璇;吴昊昱;石毅;周余来;;骨髓间充质干细胞联合维生素E对急性肾损伤的治疗研究[A];第三届泛环渤海(七省二市)生物化学与分子生物学会——2012年学术交流会论文集[C];2012年
5 何飞;张均;卢中秋;高庆龄;沙杜鹃;范国峰;裴力刚;;冠状动脉支架植入术后急性肾损伤的危险因素和预后分析[A];中华医学会急诊医学分会第十六次全国急诊医学学术年会论文集[C];2013年
6 韩国锋;高晶;顾勇;孙晶;张金元;;203例急性肾损伤流行病学分析[A];《中华急诊医学杂志》第八届组稿会暨急诊医学首届青年论坛论文汇编[C];2009年
7 王琴;倪兆慧;牟姗;严玉澄;顾乐怡;戴慧莉;朱铭力;施蓓莉;车妙琳;吴青伟;;尿白介素-18在慢性肾脏病基础上急性肾损伤诊断中的意义[A];第10届全国中西医结合肾脏病学术会议论文汇编[C];2009年
8 李家瑞;由希雷;;急性肾损伤的营养治疗[A];中华医学会第12次全国内科学术会议论文汇编[C];2009年
9 闫素英;;急性肾损伤[A];2010全国中西医结合危重病、急救医学学术会议论文汇编[C];2010年
10 陈香美;谢院生;;急性肾损伤的修复再生[A];第十一届全国中西医结合肾脏病学术会议论文汇编[C];2010年
相关重要报纸文章 前10条
1 记者 谭嘉;急性肾损伤防治应城乡有别[N];健康报;2013年
2 湖南省人民医院 主任医师 梁玉梅 主治医师 陈a音;滥用抗生素引发急性肾损伤[N];大众卫生报;2013年
3 ;药物对体外冲击波碎石术所致老年人急性肾损伤的防护作用[N];中国医药报;2003年
4 记者 唐闻佳;两成急性肾损伤源自乱吃药[N];文汇报;2011年
5 本报记者 朱国旺;急性肾衰要早期诊治规范用药[N];中国医药报;2008年
6 海上飞鱼;透析,并非越多越好[N];医药经济报;2008年
7 驻京记者 王丹;高端CT对比剂临床使用悄然升温[N];医药经济报;2007年
8 本报记者 朱国旺;黏度在对比剂肾病发生中具有重要意义[N];中国医药报;2009年
9 本报记者 李颖;警惕慢性肾脏病流行[N];科技日报;2013年
10 记者 朱国旺;对比剂安全性比成像效果更重要[N];中国医药报;2010年
相关博士学位论文 前10条
1 陈纯波;急性失代偿性心力衰竭引起慢性肾脏病患者的急性肾损伤:尿血管紧张素原的预测作用及预后价值[D];南方医科大学;2014年
2 周蒙;PROGRANULIN在急性肾损伤中的作用及机制研究[D];山东大学;2016年
3 杞少华;骨髓间充质干细胞对顺铂所致大鼠急性肾损伤的保护作用和分子机制[D];武汉大学;2013年
4 蒋春明;抑制糖原合成酶激酶3β诱导巨噬细胞表型转化及其对组织损伤的保护作用[D];南京大学;2016年
5 赵维;盐酸戊乙奎醚预先给药对大鼠横纹肌溶解致急性肾损伤的影响及其相关机制的研究[D];中国人民解放军医学院;2016年
6 孙凯;肝移植术中静脉静脉转流对术后急性肾损伤的保护作用[D];浙江大学;2016年
7 刘远辉;miRNA-20a靶向Atg7影响的自噬对造影剂诱导的急性肾损伤的机制研究及新的急性肾损伤危险因素探讨[D];南方医科大学;2016年
8 李建中;Rictor/mTORC2在急性与慢性肾损伤中作用及机制的研究[D];南京医科大学;2016年
9 关雪晶;Klotho对缺血再灌注急性肾损伤中细胞自噬的作用及其机制研究[D];上海交通大学;2015年
10 王璇;不同药物联合预防泛影葡胺诱导急性肾损伤的机制研究[D];天津医科大学;2016年
相关硕士学位论文 前10条
1 袁莹;急诊经皮冠状动脉介入治疗术后对比剂诱导的急性肾损伤的危险因素[D];北京协和医学院;2017年
2 卢海源;Cs菌丝粉对大鼠脓毒性急性肾损伤中klotho蛋白表达的影响[D];河北联合大学;2014年
3 李萌;血清胱抑素C和双源CT肾灌注成像在评估Debakey Ⅰ型主动脉夹层围手术期急性肾损伤中的价值[D];河北医科大学;2015年
4 潘笑悦;不同剂量顺铂诱导小鼠急性肾损伤模型观察及生物学指标检测[D];新乡医学院;2015年
5 国建;急性肾损伤的病因分析及预后危险因素探讨[D];南方医科大学;2015年
6 朱建刚;床旁超声评估严重创伤后急性肾损伤的初步研究[D];浙江大学;2015年
7 徐嘉琪;血尿酸升高和RAS抑制剂的使用:两种非传统危险因素与心血管住院患者急性肾损伤的关系[D];南方医科大学;2015年
8 张仙珍;痛风性关节炎发生急性肾损伤危险因素的临床研究[D];浙江大学;2015年
9 王韦乐;小儿先天性心脏病术后并发急性肾损伤危险因素及腹膜透析应用的探讨[D];南京大学;2014年
10 李U,
本文编号:2048737
本文链接:https://www.wllwen.com/yixuelunwen/xxg/2048737.html